ClinicalTrials.gg
CompletedNCT03829189Updated Nov 27, 2020

High-fiber Diet on the Body and the Brain

An interventional study of inulin and maltodextrin in Diet Modification and Overweight, sponsored by Max Planck Institute for Human Cognitive and Brain Sciences. Completed at 1 site in Germany. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-27.

Sponsored by Max Planck Institute for Human Cognitive and Brain Sciences · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
61
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 151 studies in Overweight with a site in Germany — 40 open to participants now, 62 under way, 34 of them phase 3. Overweight · Germany.

Enrollment
113th of 142
61 · median 131
Started
2019
with 10 others
No phase
53 of 151
11 open now
Registered
50th of 151
by date

Among the 151 studies in Overweight with a site in Germany, this one is the 113th largest by enrollment of the 142 interventional ones that give a count, is one of 11 that started in 2019, is one of 53 with no phase, and was the 50th registered.

Overweight

3,623 studies on the registry are indexed under Overweight; 864 are open to participants now.

Browse Overweight studies →

Open to participants now

40 of the 151 studies in Overweight with a site in Germany are open now. Recruiting first, the newest first:

35 more — sign in →

All 40 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 538 Overweight studies recruiting now, 163 (30%) set no upper age limit and 348 (65%) stop at 75 or younger; 64 take children under 18; 206 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 151 studies in Overweight with a site in Germany, or all of them as a file.
02

Study summary

The central research question aims to understand what drives individuals to make and maintain a vegan / vegetarian dietary decision, to investigate whether there are possible predictors that might influence such a decision and whether personality differences already exist or can only be measured after the change in diet. The investigators will examine the effects of a high-fiber diet on food wanting on a neural and on a behavioral level. The microbiome is suggested to mediate the expected changes in food wanting.

03

Conditions studied

  • Diet Modification
  • Overweight

Browse trials for

Keywords

  • microbiome
  • food wanting
  • memory
  • fiber
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • body-mass-index 25-30kg/m\^2
  • females on only

Exclusion criteria

Exclusion Criteria:

  • current neurological or psychiatric illness
  • daily consumption of more than 50 g of alcohol, more than 10 cigarettes or more than 6 cups of coffee
  • use of antidepressants or other centrally acting drugs
  • type 2 diabetes mellitus or other serious metabolic disorders
  • MRI (e.g. cardiac pacemaker, drug pump, shunts)
  • major untreated medical condition, including gastrointestinal organs, lungs, heart, cardiovascular system, liver and kidney)
  • diet-related restrictions (food allergies, food intolerances, known nutrient deficiencies or a recent history of dieting or restrictive eating behaviour, including vegan, vegetarian diet)
  • current pregnancy or lactation
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
61 participants (actual)

Study arms

  • Active comparator
    inulin

    Dietary Supplement: inulin

  • Placebo comparator
    maltodextrin

    Dietary Supplement: maltodextrin

Interventions

  • Dietary supplementinulin

    prebiotic supplement

  • Dietary supplementmaltodextrin

    placebo supplement

06

What researchers measure

Primary outcomes

  1. fMRI BOLD activity during food wanting

    Time frame: 14 days

  2. microbial alpha and beta diversity

    The taxonomic structure of the microbial community will be determined using 16S rRNA gene sequencing. The reads from the sequencing data will be assigned to taxa by sequence similarity using puplic available data bases. Relative distribution of microbial taxa is then based on the number of reads assigned to each taxa. For the description of the the community the alpha diversity of each sample will be determined based on species richness, evenness of species distribution which is combined in the single value of the Shannon diversity index. Furthermore beta-diversity, how the microbial communities differ between sample, will be analysed by principal component analysis as well as non-metric multidimensional scaling. In addition, for each taxa significant difference between sample groups will be assessed by comparing the relative number of reads.

    Time frame: 14 days

Secondary outcomes

  1. fMRI BOLD activity memory performance

    Time frame: 14 days

  2. positive and negative affect

    PANAS (Positive and Negative Affect Schedule); scores can range from 10 - 50, with higher (lower) scores representing higher (lower) levels of positive (negative) affect

    Time frame: 14 days

  3. mood

    POMS (Profile of Mood States); four scales (Depression/Anxiety, Fatigue, Vigor, Anger), 35 items, 7 point scale, instruction "How you have been feeling during the past 24 hours?"

    Time frame: 14 days

  4. emotional health

    BDI-II (Beck Depression Inventory); score minimum 0 to maximum 21

    Time frame: 14 days

  5. well-being

    WHO-5 (World Health Organization Well-Being Index); measures life quality and life contentment; score minimum 0 to maximum 5 with higher score representing higher life quality and life contentment

    Time frame: 14 days

  6. satiety

    self-reported hunger scale; visual analogue scale; score minimum 0 to maximum 8

    Time frame: 14 days

  7. serum lipid metabolism markers

    total cholesterol, triglycerides, high density lipoprotein, low density lipoprotein

    Time frame: 14 days

  8. serum glucose metabolism markers

    glucose, insulin

    Time frame: 14 days

  9. serum glucose metabolism markers

    long-term glucose marker HbA1C

    Time frame: 14 days

  10. serum inflammatory markers

    high sensitivity C-reactive protein, interleukin-6

    Time frame: 14 days

  11. hunger hormones

    leptin, ghrelin, Glucagon-like peptide-1 (GLP-1), peptide YY

    Time frame: 14 days

  12. serum microbial metabolic markers

    short-chain fatty acids (SCFA), trimethylamine N-oxide (TMAO), bile acids

    Time frame: 14 days

  13. personality traits

    BFMM (BIG FIVE Mine Marker); measures the Big Five personality traits as states; 5 subscales (neuroticism, extraversion, openness, agreeableness, conscientiousness); higher scores means being more extreme for a certain state

    Time frame: 14 days

  14. gastrointestinal health

    GQLI-10 (Gastrointestinal Quality of Life Index); 10 items to measure quality of life regarding gastrointestinal symptoms; the higher the score the stronger the symptoms

    Time frame: 14 days

07

Study locations

1 site
  • Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences
    Leipzig, Saxonia 04103, Germany
08

References and documents

Publications

  • Medawar E, Haange SB, Rolle-Kampczyk U, Engelmann B, Dietrich A, Thieleking R, Wiegank C, Fries C, Horstmann A, Villringer A, von Bergen M, Fenske W, Veronica Witte A. Gut microbiota link dietary fiber intake and short-chain fatty acid metabolism with eating behavior. Transl Psychiatry. 2021 Oct 1;11(1):500. doi: 10.1038/s41398-021-01620-3. PubMed 34599144 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2019 to primary completion in Nov 2020, 22 months.

Of 1,314 non-industry interventional studies with no phase under Overweight, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 38. This study's 22 months is above that.

Counting every sponsor, half of 1,427 studies reached it within 17 months; a quarter within 7 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 11, 2019
First posted
Feb 4, 2019
StartActual
Jan 14, 2019
Primary completionActual
Nov 24, 2020
CompletionActual
Nov 24, 2020
Last update
Nov 27, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03829189
Lead sponsor
Max Planck Institute for Human Cognitive and Brain Sciences
Responsible party
Sponsor
First posted
Feb 4, 2019
Start date
Jan 14, 2019
Primary completion
Nov 24, 2020
Completion
Nov 24, 2020
Last update
Nov 27, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Inulin

Start the discussion